Venus Medtech (Hangzhou) Inc Class H VMTHF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.64
- Day Range
- $0.01–0.01
- 52-Week Range
- $0.01–0.64
- Bid/Ask
- $0.01 / $1.82
- Market Cap
- $4.76 Mil
- Volume/Avg
- 1,312 / 1,312
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.07
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Venus Medtech (Hangzhou) Inc is engaged in the development and commercialization of transcatheter solutions for structural heart diseases. It has two TAVR products on the market, namely VenusA-Valve, and VenusA-Plus. VenusA-Valve is its first-generation TAVR device, which is used to treat severe Aortic Stenosis (AS) using a transcatheter approach. VenusA-Plus is an upgraded product of VenusA-Valve. Geographically all of the revenue is derived from Mainland China.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 865
- Website
- https://www.venusmedtech.com
Comparables
Valuation
|
Metric
|
VMTHF
|
688351
|
02291
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 42.54 |
Price/Book Value | 0.01 | 7.10 | 3.80 |
Price/Sales | 0.07 | 32.72 | 22.40 |
Price/Cash Flow | — | — | 43.97 |
Price/Earnings
VMTHF
688351
02291
Financial Strength
|
Metric
|
VMTHF
|
688351
|
02291
|
|---|---|---|---|
Quick Ratio | 1.54 | 14.41 | 24.30 |
Current Ratio | 2.00 | 15.75 | 25.52 |
Interest Coverage | −11.27 | 0.04 | 5.47 |
Quick Ratio
VMTHF
688351
02291
Profitability
|
Metric
|
VMTHF
|
688351
|
02291
|
|---|---|---|---|
Return on Assets (Normalized) | −13.63% | −1.18% | 9.11% |
Return on Equity (Normalized) | −20.35% | −1.28% | 9.40% |
Return on Invested Capital (Normalized) | −15.38% | −1.51% | 8.69% |
Return on Assets
VMTHF
688351
02291
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Gszrktdlq | Hxscty | $186.1 Bil | |
SYK
| Stryker Corp | Tgtppttyq | Ybpnv | $128.9 Bil | |
MDT
| Medtronic PLC | Pqrdjbz | Nybbdx | $107.4 Bil | |
BSX
| Boston Scientific Corp | Ktmdnrgx | Lfsdpg | $106.6 Bil | |
EW
| Edwards Lifesciences Corp | Ycxvqdlbj | Yjpvcv | $51.8 Bil | |
DXCM
| DexCom Inc | Wppbnvsqvf | Bzfz | $49.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Pzzljqgd | Pbyr | $25.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Bbtvhdsgh | Tyqdkpf | $24.8 Bil | |
ALGN
| Align Technology Inc | Qkmzbds | Hjxpt | $22.9 Bil | |
PODD
| Insulet Corp | Hbjfkbppj | Rvsym | $11.9 Bil |